375 related articles for article (PubMed ID: 19578113)
1. The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab.
Naretto C; Baldovino S; Rossi E; Spriano M; Roccatello D
Lupus; 2009 Aug; 18(9):856-7. PubMed ID: 19578113
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of infliximab in active SLE: a pilot study.
Uppal SS; Hayat SJ; Raghupathy R
Lupus; 2009 Jul; 18(8):690-7. PubMed ID: 19502264
[TBL] [Abstract][Full Text] [Related]
3. [Sneddon-Wilkinson disease: efficacy of intermittent adalimumab therapy after lost response to infliximab and etanercept].
Versini M; Mantoux F; Angeli K; Passeron T; Lacour JP
Ann Dermatol Venereol; 2013 Dec; 140(12):797-800. PubMed ID: 24315227
[TBL] [Abstract][Full Text] [Related]
4. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
5. Subcorneal pustular dermatosis treated successfully with adalimumab.
de Encarnação Roque Diamantino F; Dias Coelho JM; Macedo Ferreira AM; Fidalgo AI
Eur J Dermatol; 2010; 20(4):512-4. PubMed ID: 20395190
[No Abstract] [Full Text] [Related]
6. Sneddon-Wilkinson disease treated with etanercept: report of two cases.
Berk DR; Hurt MA; Mann C; Sheinbein D
Clin Exp Dermatol; 2009 Apr; 34(3):347-51. PubMed ID: 18699836
[TBL] [Abstract][Full Text] [Related]
7. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) occurring in association with nodal marginal zone lymphoma: a case report.
Ratnarathorn M; Newman J
Dermatol Online J; 2008 Aug; 14(8):6. PubMed ID: 19061566
[TBL] [Abstract][Full Text] [Related]
8. A case of subcorneal pustular dermatosis in association with monoclonal IgA gammopathy successfully treated with acitretin.
Canpolat F; Akpinar H; Cemil BC; Eskioğlu F; Oztürk E
J Dermatolog Treat; 2010 Mar; 21(2):114-6. PubMed ID: 20136575
[TBL] [Abstract][Full Text] [Related]
9. Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease).
Voigtländer C; Lüftl M; Schuler G; Hertl M
Arch Dermatol; 2001 Dec; 137(12):1571-4. PubMed ID: 11735706
[No Abstract] [Full Text] [Related]
10. Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis.
Méndez-Flores S; Charli-Joseph Y; Saeb-Lima M; Orozco-Topete R; Fernández Sánchez M
Dermatology; 2013; 226(1):1-4. PubMed ID: 23467024
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.
Ideguchi H; Ohno S; Takase K; Hattori H; Kirino Y; Takeno M; Ishigatsubo Y
Rheumatology (Oxford); 2007 Oct; 46(10):1621-2. PubMed ID: 17726035
[No Abstract] [Full Text] [Related]
12. Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids.
Bonifati C; Trento E; Cordiali Fei P; Muscardin L; Amantea A; Carducci M
Clin Exp Dermatol; 2005 Nov; 30(6):662-5. PubMed ID: 16197383
[TBL] [Abstract][Full Text] [Related]
13. [Non-microbial pustulosis and systemic lupus erythematosus].
López Estebaranz JL; Vanaclocha Sebastian F; Iglesias Díez L
Ann Dermatol Venereol; 1996; 123(6-7):401-2. PubMed ID: 8959066
[No Abstract] [Full Text] [Related]
14. TNF-alpha blockade with infliximab in a patient with lupus erythematosus profundus.
Günther C; Aringer M; Lochno M; Kämmerer E; Bauer A; Wozel G; Meurer M
Acta Derm Venereol; 2012 Jul; 92(4):401-3. PubMed ID: 22170286
[No Abstract] [Full Text] [Related]
15. Refractory Takayasu arteritis successfully treated with infliximab.
Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
[TBL] [Abstract][Full Text] [Related]
16. Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis.
Kent PD; Davis JM; Davis MD; Matteson EL
Arthritis Rheum; 2002 Aug; 46(8):2257-8; author reply 2259. PubMed ID: 12209539
[No Abstract] [Full Text] [Related]
17. Pustular vasculitis disclosing a systemic lupus erythematosus.
Martín JM; Ramón D; Monteagudo C; Alonso V; Jordá E
Int J Dermatol; 2006 Dec; 45(12):1426-7. PubMed ID: 17184245
[No Abstract] [Full Text] [Related]
18. Sneddon-Wilkinson disease in a patient with rheumatoid arthritis.
Iobst W; Ingraham K
Arthritis Rheum; 2005 Dec; 52(12):3771. PubMed ID: 16329105
[No Abstract] [Full Text] [Related]
19. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.
Geissal ED; Wernick R
J Clin Rheumatol; 2010 Jun; 16(4):185-7. PubMed ID: 20414125
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
